(Q33411548)
Statements
1 reference
A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer (English)
1 reference
Piotr L Chłosta
1 reference
Bradley G Somer
1 reference
Begoña Mellado
1 reference
José Manuel Cervera Grau
1 reference
Daniel Castellano
1 reference
Christoph Reuter
1 reference
Michael Stöckle
1 reference
Jörn Kamradt
1 reference
Joanna Pikiel
1 reference
Ignacio Durán
1 reference
Steffen Wedel
1 reference
Sophie Callies
1 reference
Valérie André
1 reference
Karla Hurt
1 reference
Jacqueline Brown
1 reference
Michael Lahn
1 reference
Bernhard Heinrich
1 reference
6 November 2013
1 reference
1 reference
Identifiers
1 reference